What does PT-141 do for women?

Its FDA approved use, as Vyleesi, is treating low sexual desire that causes distress (hypoactive sexual desire disorder) in women who have not reached menopause. That is based on studies with more than 1,200 people. It acts on melanocortin receptors in the brain, not directly on blood flow. That is how it is thought to affect desire, not just physical arousal.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of sexual health and hormone peptides. PT-141, melanotan, oxytocin, gonadorelin, and kisspeptin-10.